Investors

We have two manufacturing sites – 1 in Hyderabad and 1 in Goa. These sites manufacture products with the stringent global quality guidelines, also approved by regulatory agencies such as Medicines and Healthcare Products Regulatory Agency (MHRA) from United Kingdom, Regierungspräsidium Darmstadt from Germany, Medicines Control Council (MCC) from South Africa, Taiwan Food & Drug Administration (TFDA) from Taiwan, State Administration of Ukraine on Medicinal Products (SAUMP) from Ukraine, Therapeutic Goods Administration (TGA) from Australia, Health Authority from Canada, Agência Nacional de Vigilância Sanitária (ANVISA) from Brazil, and Pharmacy & Poisons Board (PPB) from Kenya. In addition to these, regulatory approvals as per Indian Legislation also endorse the quality and safety of the products manufactured at our sites. Sanofi India Limited also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), Eye/Ear drops, ampoules, vials, creams and ointments. These products are manufactured in accordance with the same quality standards as those prevalent at its own manufacturing sites for domestic consumption and for export to Russia, the Ukraine and other CIS countries.

For more information on Sanofi in India – visit www.sanofi.in